PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 134 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,274,000 | +34.4% | 294,800 | +24.0% | 0.01% | +33.3% |
| Q2 2019 | $948,000 | -44.3% | 237,700 | -25.2% | 0.01% | -35.7% |
| Q1 2019 | $1,703,000 | +4.5% | 317,700 | 0.0% | 0.01% | -6.7% |
| Q4 2018 | $1,630,000 | -57.4% | 317,700 | -19.4% | 0.02% | -42.3% |
| Q3 2018 | $3,825,000 | -9.2% | 394,369 | -4.5% | 0.03% | -10.3% |
| Q2 2018 | $4,211,000 | -16.9% | 412,869 | +6.0% | 0.03% | -17.1% |
| Q1 2018 | $5,066,000 | -21.4% | 389,669 | +8.2% | 0.04% | -18.6% |
| Q4 2017 | $6,449,000 | -12.4% | 360,269 | +22.9% | 0.04% | -12.2% |
| Q3 2017 | $7,359,000 | +7.9% | 293,200 | +3.6% | 0.05% | +8.9% |
| Q2 2017 | $6,818,000 | +167.1% | 282,900 | +113.3% | 0.04% | +164.7% |
| Q1 2017 | $2,553,000 | – | 132,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |